Advertisement

Topics

Goldshield Group plc Company Profile

12:40 EST 14th December 2018 | BioPortfolio

The first pharmaceutical product was acquired from Glaxo in 1992 and there have been subsequent product acquisitions from SmithKline Beecham, Medeva, Warner Lambert and American Home Products. Between 1991 and 1993, the Group raised equity finance of £1.0 million from individual investors, many of whom are doctors, pharmacists, or from within the pharmaceutical industry. The Group became profitable in the year ended 31 March 1993.

Location

NLA Tower 12-16 Addiscombe Road
Croydon
Surrey
CR0 0XT
United Kingdom

Contact

Phone: 44 (0) 208 649 8500
Fax: 44 (0) 208 686 0807
Email: info@goldshieldplc.com


News Articles [668 Associated News Articles listed on BioPortfolio]

Zur Rose Group announces result of rights take-up

EQS Group-News: Zur Rose Group AG / Key word(s): Capital Increase 28.11.2018 / 17:35 Under the following link, you will find a press release of the Zur Rose Group.   https://zurrosegrou...

Zur Rose Group successfully concludes rights issue and announces offer price of CHF 93 per new share

EQS Group-News: Zur Rose Group AG / Key word(s): Capital Increase 29.11.2018 / 07:00 Under the following link, you will find a press release of the Zur Rose Group.   https://zurrosegrou...

Maricann Group Inc.: Mit Volldampf in die Zukunft! - CEO Ben Ward gibt Ausblick über hervorragende Entwicklung der Wayland Group

Dow Jones hat von EQS/DGAP eine Zahlung für die Verbreitung dieser Pressemitteilung über sein Netzwerk erhalten. DGAP-Media / 2018-11-21 / 10:42 *Unternehmen: Wayland Group (ehemals Maricann Group.....

Delek Group Announces Consolidated Second Quarter 2018 Results

TEL AVIV, Israel, Aug. 30, 2018 /PRNewswire/ -- Delek Group Ltd. (TASE: DLEKG) (OTC: DGRLY) (hereinafter: "Delek Group" or "The Group") announced today its results Read more...

#Cannabisstocks: Cronos Group (NASDAQ: $CRON) (TSX: $CRON.TO) Confirms Discussions Regarding Potential Investment by Altria Group (NYSE: $MO)

TORONTO - December 4, 2018 (Investorideas.com Newswire) Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos Group" or the "Company") confirmed that it is engaged in discussions concerning a potentia...

Maricann Group Inc.: Sensations Coup! Einstieg in argentinischen Cannabis Markt - Wayland Group erwirbt über 800 Hektar Anbaufläche!

Dow Jones hat von EQS/DGAP eine Zahlung für die Verbreitung dieser Pressemitteilung über sein Netzwerk erhalten. DGAP-Media / 2018-12-11 / 07:20 *Unternehmen: Wayland Group (ehemals Maricann Group.....

Capital increase of the Zur Rose Group: Further information on the rights issue

EQS Group-News: Zur Rose Group AG / Key word(s): Capital Increase 04.12.2018 / 07:00 Under the following link, you will find a press release of the Zur Rose Group.   https://zurrosegrou...

Capital increase of Zur Rose Group: Further information on the rights issue

EQS Group-News: Zur Rose Group AG / Key word(s): Capital Increase 03.12.2018 / 06:00 Under the following link, you will find a press release of the Zur Rose Group.   https://zurrosegrou...

PubMed Articles [1742 Associated PubMed Articles listed on BioPortfolio]

Does Timing of Surgery Affect Treatment of the Terrible Triad of the Elbow?

BACKGROUND This study investigated the influence of surgical timing on the treatment of terrible triad of the elbow (TTE). MATERIAL AND METHODS After exclusion, 63 patients were enrolled in this study...

Isolation and exploitation of minority: Game theoretical analysis.

We investigate various group-size distributions occurring in a situation where each group's resource is exposed to appropriation by other groups. The amount of appropriation depends on the size differ...

Group I introns are widespread in archaea.

Group I catalytic introns have been found in bacterial, viral, organellar, and some eukaryotic genomes, but not in archaea. All known archaeal introns are bulge-helix-bulge (BHB) introns, with the exc...

The role of group cohesion in a group-based behavioral weight loss intervention.

Behavioral weight loss interventions are often delivered in groups. Group cohesion may enhance program attendance and, thereby, weight loss. In this secondary analysis, our goals were to: (1a) assess ...

Experimental animal study of docetaxel combined with carboplatin in the treatment of retinoblastoma.

The synergistic effects of docetaxel (DTX) combined with carboplatin in the treatment of retinoblastoma (RB) was explored in mouse RB xenografts compared with carboplatin alone and DTX alone groups. R...

Clinical Trials [4118 Associated Clinical Trials listed on BioPortfolio]

The Influence of Hypotensive Drugs on Mineral Status in Experimental and Clinical Studies

The aim of the study was to evaluate the effects of hypotensive treatment combined with a higher zinc supply in the diet and supplements on the mineral status and selected biochemical para...

Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-828 in Healthy Participants

The purpose of this study is to evaluate the safety and tolerability of single oral doses of TAK-828 in healthy non-Japanese and Japanese participants.

Ultrasound and Exercises in Knee Osteoarthritis

The aim of this investigation is to compare the effects of continuous (CUS) and pulsed (PUS) ultrasound associated with a program of exercises on pain, range of motion, muscle strength, fu...

Technical Development of Multi-Parametric Renocerebral MRI

The purpose of the study is to investigate the associations of the age-related changes in the brain, kidneys and cognitive performance in healthy adults by utilizing multiple anatomic and ...

The T2T Study of RA Based on SSDM

This study evaluate the Smart System of Disease Management(SSDM)to improve the treat-to-target(T2T) and the safety of drug in the treatment of rheumatoid(RA). All participants will be ...

Companies [1641 Associated Companies listed on BioPortfolio]

Goldshield Group

Goldshield Group plc

The first pharmaceutical product was acquired from Glaxo in 1992 and there have been subsequent product acquisitions from SmithKline Beecham, Medeva, Warner Lambert and American Home Products. Between...

W2 Group, Inc.

W2 Group is a global marketing services ecosystem that helps CMOs in their new role as builders of communities and content aggregators. W2 Group companies, including Digital ...

PharmEvo (Pvt.) Ltd.

PharmEvo is backed by a reputable corporate group with a history of successful business ventures spread over 30 years. The group made its debut in 1971, with the sales and marketing of prestigious bra...

ACE Group

Celebrating 25 years of insuring progress, the ACE Group is a global leader in insurance and reinsurance serving a diverse group of clients. Headed by ACE Limited (NYSE:ACE), a co...

More Information about "Goldshield Group plc" on BioPortfolio

We have published hundreds of Goldshield Group plc news stories on BioPortfolio along with dozens of Goldshield Group plc Clinical Trials and PubMed Articles about Goldshield Group plc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Goldshield Group plc Companies in our database. You can also find out about relevant Goldshield Group plc Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record